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Case Report
Celiac disease and constipation: an uncommon atypical 
clinical manifestation
Doença celíaca e constipação: uma manifestação clínica atípica e pouco frequente
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ABSTRACT
Objective: To report two cases of patients with celiac dis-
ease (CD) whose main complaint was chronic constipation.
Case description: Two girls, aged 18 and 30 months, 
had chronic constipation refractory to standard treatment. 
Both patients concomitantly evidenced low weight gain and 
short stature. The investigation of the digestive-absorptive 
function was positive for IgA antibodies against tissue trans-
glutaminase. The diagnosis of CD was confirmed by a small 
bowel biopsy that showed moderate/severe villous atrophy 
and increased intraepithelial lymphocytic infiltration. One 
month after starting the dietary treatment with a gluten-
free diet, both patients recovered from constipation, with 
the passage of soft stools daily.
Comments: CD may be presented in the classical, 
asymptomatic or atypical forms. In the latter form, isolated 
manifestations, surch as constipation, delay the diagnosis 
of the disease.
Key-words: constipation; celiac disease; child.
RESUMO
Objetivo: Relatar dois casos de doença celíaca (DC) com 
manifestação de constipação.
Descrição do caso: Dois pacientes do sexo feminino, com 
18 e 30 meses de idade, respectivamente, apresentando história 
de constipação crônica refratária ao tratamento. Como apresen-
tavam concomitantemente baixo ganho ponderal e estatural, 
foi realizada investigação da função digestiva-absortiva, que 
resultou positiva para o anticorpo IgA antitransglutaminase 
tecidual. O diagnóstico de DC foi confirmado por biópsia de 
intestino delgado que revelou atrofia vilositária moderada/
intensa e infiltrado linfocítico intraepitelial. Um mês após 
o início do tratamento com dieta isenta de glúten, ambas as 
pacientes passaram a apresentar fezes pastosas diariamente.
Comentários: A DC pode se apresentar nas formas clás-
sica, assintomática e atípica, em que manifestações isoladas 
como constipação podem retardar o diagnóstico.
Palavras-chave: constipação intestinal; doença celíaca; 
criança.
RESUMEN
Objetivo: Relatar dos casos de enfermedad celíaca (EC) 
con manifestación de constipación.
Descripción del caso: Dos pacientes del sexo femenino, 
con 18 y 30 meses de edad, respectivamente, presentando 
historia de constipación crónica refractaria al tratamiento. 
Como presentaban concomitantemente baja ganancia de peso 
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ponderal y estatural, se realizó investigación de la función 
digestiva-absortiva, que resultó positiva para el anticuerpo 
IgA antitransglutaminasa tejidual. El diagnóstico de EC 
fue confirmado por biopsia de intestino delgado que reveló 
atrofia vellositaria moderada/intensa e infiltrado linfocítico 
intraepitelial. Un mes después del inicio del tratamiento con 
dieta exenta de gluten, ambas pacientes pasaron a presentar 
heces pastosas diariamente.
Comentarios: La EC puede presentarse en la forma clá-
sica, asintomática y atípica, en que manifestaciones aisladas 
como constipación pueden retardar el diagnóstico.
Palabras clave: constipación intestinal; enfermedad 
celíaca; niño.
Introduction
Celiac disease (CD) is a permanent intolerance to 
gluten that occurs in genetically susceptible individuals 
and is characterized by complete or partial atrophy of the 
mucosa of the proximal small bowel, hyperplasia of the 
intestinal crypts and intraepithelial lymphocytic infiltra-
tion, leading to malabsorption of dietary nutrients(1). CD 
is considered a chronic immune-mediated enteropathy(2) 
and is closely associated with the major histocompat-
ibility complex (MHC) class II molecules HLA-DQ2 
and HLA-DQ8(3).
Classical CD, described in 1888 by Samuel Gee in 
Sdepanian, Morais & Fagundes-Neto(3), is characterized by 
chronic diarrhea, abdominal distension, weight loss and/or 
failure to thrive, vomiting, abdominal pain, irritability, and 
gluteal wasting(4). Although this is still the most common 
form of CD, atypical and clinically silent presentations are 
being reported with increasing frequency.
Constipation is rarely described as an atypical manifes-
tation of CD, particularly in pediatric patients. In 1972, 
Egan-Mitchell and McNicholl(5) analyzed a series of 112 
children with a diagnosis of CD and found that 12 (10.7%) 
had constipation. On the other hand, Sharma, Poddar and 
Yachha(6) conducted a study of 18 children with suspected 
CD in 2007 and found that only one (4%) had constipation 
as an atypical manifestation.
Within this context, we report two cases of patients with 
CD who presented with the atypical manifestation of chronic 
constipation. This report was approved by the Universidade 
Federal de São Paulo School of Medicine Research Ethics 
Committee.
Case description
Case 1
A 36-month-old girl presented with an 18-month 
history of constipation. The patient had been receiv-
ing follow-up at the Hospital São Paulo Department 
of Orthopedics due to a history of “chronic recurrent 
torticollis” (sic). Due to a concomitant complaint of 
chronic constipation, she was referred to our service, 
the Department of Pediatric Gastroenterology of the 
aforementioned hospital. According to her mother, the 
patient began to exhibit difficulty with bowel movements 
at the age of 18 months, with passage of hardened, thick, 
sausage-shaped stools with cracks on the surface. The 
patient strained and reported pain during bowel move-
ments, and stools were occasionally coated with strands 
of bright red blood. These symptoms had thus far been 
managed unsuccessfully with administration of low-dose 
lactulose and periodic use of glycerin suppositories.
The patient had been exclusively breastfed until age 6 
months. Throughout this period, she reportedly had two 
to three bowel movements per day, passing soft stools with 
no difficulty. At age 7 months, the patient was placed on 
a weaning diet consisting of whole cow’s milk and instant 
cereal (Mucilon® rice and oat formula) and gluten-containing 
solids (pasta). Relevant family history included a 6-year-old 
sibling with difficult-to-control epilepsy since age 3 years.
Physical examination revealed a weight of 11.4kg and 
height of 88.5cm (both within the 3rd percentile for age), 
mild pallor, and a palpable, hard mass extending across the 
left lower quadrant and left flank. Inspection of the anus 
revealed no abnormalities. A small amount of hardened 
stools was present in the rectal vault.
The following diagnostic hypotheses were considered: 
wasting and stunting (z scores: weight-for-age, -1.9; 
height-for-age, -1.6; weight-for-height, -1.5), chronic 
constipation, and iron deficiency anemia. A comprehen-
sive workup was requested (complete blood count, serum 
iron and ferritin, thyroid-stimulating hormone and free 
thyroxine, urinalysis and urine culture, stool ova and 
parasites, and plain abdominal radiographs). A monoso-
dium/disodium phosphate (Fleet®) enema was prescribed 
for fecal disimpaction, followed by maintenance lactulose 
(Lactulona®), 2mL/kg/day.
The patient returned one month later for follow-up. 
There had been no improvement in constipation; how-
ever, the prescribed therapeutic regimen had not been 
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followed. Due to the patient’s poor weight and height 
and low serum iron and ferritin levels (Table 1), further 
investigation with hydrogen breath testing after glucose, 
lactose, fructose, and lactulose loading was requested for 
assessment of digestive-absorptive function (Table 2), as 
were serum anti-tissue transglutaminase (tTG) antibody 
and immunoglobulin A (IgA) levels. Glucose, lactose, 
and lactulose load tests were within normal limits, with 
elevations in exhaled H
2
 level <20ppm above fasting 
(baseline) levels. In the lactulose load test, an increase in 
exhaled H
2
 levels is expected at 60 minutes, due to the 
non-absorbable nature of this carbohydrate (the elevated 
level reflects the fermentative action of the colonic flora). 
The fructose load test was indicative of fructose mal-
absorption, but not intolerance, as the patient did not 
exhibit any symptoms of the latter. As serum anti-tissue 
transglutaminase antibody levels were above normal 
(33.62 units; reference range, <20), an endoscopic small 
bowel biopsy was scheduled. The patient’s serum IgA 
level was 111.1mg/dL (reference range, 24–190mg/dL). 
Histological examination of the biopsy specimen revealed 
patchy villous atrophy, diffuse intraepithelial lymphocy-
tosis, and slightly increased lymphoplasmacytic infiltra-
tion of the lamina propria (Marsh stage 3A)(7) (Figures 1 
and 2). In view of these findings, a diagnosis of CD was 
made and the patient was placed on a gluten-free diet. 
Within two months of dietary treatment, the patient was 
having daily bowel movements and passing soft stools.
Case 2
A 30-month-old girl presented with a history of chron-
ic constipation and fecal soiling since age 27 months. 
According to the patient’s mother, bowel movements 
were painful and occurred only once every five days; 
stools were large and hardened, but no blood or other 
pathological elements were present. Treatment with 
below-recommended doses of lactulose (Farlac®) had been 
attempted with no effect. The patient received mixed 
feeding until age 8 months and, during this period, had 
two to three daily bowel movements, passing soft stools 
with no difficulty. A solid diet was introduced at age 
6 months, consisting of an age-appropriate cow’s milk 
formula and age-appropriate solids as recommended by 
the child’s pediatrician. Wheat-derived flour was intro-
duced at this time. Relevant family history included a 
grandfather with Crohn’s disease and mother with chronic 
constipation.
On physical examination, weight was 11.7kg and height 
was 92cm (z scores: weight-for-age, -1.37; height-for-age, 
-0.78; weight-for-height, -1.04). The patient appeared 
Parameters Case 1 Case 2 Reference range
Iron (mcg/dL) 32 85 37–170
Ferritin (ng/mL) 8.4 27.0 11.0–307.0
Thyroid-stimulating hormone (µUI/mL) 1.24 3.68 0.34–5.60
Thyroxine, free (ng/dL) 0.80 1.08 0.58–1.64
Stool, ova and parasites (three specimens) Negative – Negative
Urinalysis Normal –
Hemoglobin (g/dL) 11.5 13.5 12.0–15.5
Hematocrit (%) 35.0 42.2 35.0–45.0
Table 1 - Laboratory workup
Fructose Lactose Lactulose Glucose
Fasting 0 4 1 0
15' 0 3 0 0
30' 10 0 0 0
45' 27 0 8 0
60' 36 14 27 1
90' 15 7 20 1
120' 10 10 12 0
Table 2 - Hydrogen breath testing – case 1
Hydrogen breath test after glucose, fructose, lactose, and lactulose load. H2 levels expressed as parts per million (ppm)
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emaciated and had abdominal distension with a palpable 
mass in the left flank. The differential diagnosis included 
underweight and chronic constipation. Plain abdominal 
radiographs revealed gas and stool buildup throughout 
the colon and an apparent fecal mass retained in the rectal 
vault. A phospho-soda enema was prescribed for home dis-
impaction, followed by maintenance lactulose (2mL/kg/day) 
and mineral oil (2mL/kg/day). As the patient continued 
to exhibit constipation and growth restriction one year 
after initial presentation (weight 13.1 kg; height 98 cm; 
weight-for-age z score, -1.07), further investigations were 
requested (complete blood count, thyroid-stimulating 
hormone, free thyroxine, and ferritin) (Table 1). A CD 
serological screening panel was also requested, consisting 
of the following tests: antigliadin antibodies (AGA), IgA 
and IgG; antiendomysial antibodies (EMA); anti-tTG 
antibodies; and HLA-DQ2 and DQ8 typing.
Celiac serology was positive, to wit: EMA titers, 1:320 
(reference range, nonreactive); IgA-AGA, 9.9 (refer-
ence range, ≥1); IgG-AGA, 3.6 (reference range, ≥3); 
anti-tTG, 165; HLA-DQ2, positive. In view of these 
findings, an endoscopic duodenal biopsy was performed. 
Gross examination revealed the mosaic or “cracked-mud” 
duodenal mucosal pattern indicative of CD. Histological 
examination under conventional light microscopy showed 
moderate villous atrophy, a substantial increase in the 
number of intraepithelial lymphocytes, increased lympho-
plasmacytic infiltration of the lamina propria, and crypt 
hyperplasia (Marsh stage 2)(7). The patient was instructed 
to follow a gluten-free diet. After one month of dietary 
management, constipation had resolved completely.
Discussion
CD is a permanent, immune-mediated intolerance to 
gluten(2). In Europe and the United States, the prevalence 
of CD ranges from 1 in 100 to 1 in 200(4). In a study of 
blood donors from the city of São Paulo, Brazil, Oliveira 
et al(8) showed that CD should not be considered a rare 
disease, as its prevalence in the city was at least 1 in 214 
population.
In addition to the classic form of CD, the other rec-
ognized forms of this disease are: 1) asymptomatic or 
clinically silent – typical gluten-sensitive enteropathy, 
with no clinical manifestations. Most of these patients 
are first-degree relatives of persons with CD and insulin-
dependent diabetics(4); 2) nonclassical or atypical – char-
acterized by one or few presenting symptoms, with onset 
in late childhood; patients may present with isolated 
manifestations such as short stature, treatment-refractory 
iron deficiency anemia, arthritis or arthralgia, epileptic 
Figure 1 - Small bowel biopsy showing patchy villous 
atrophy, intraepithelial lymphocytosis, and slightly increased 
lymphoplasmacytic infiltrate in the lamina propria. H&E stain, 
original magnification 10x – case 1
Figure 2 - Case 1. Small bowel biopsy showing abundant 
villous intraepithelial lymphocytes (arrows). H&E stain, original 
magnification 100x – case 1
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seizures, enamel hypoplasia, dermatitis herpetiformis, 
elevated transaminases, precocious puberty, recurring 
abdominal pain, and constipation(4). Constipation is 
consistently cited as one of the presenting symptoms of 
atypical CD, particularly in review articles; however, it 
has only rarely been described (with supporting evidence) 
as a symptom of CD in the literature.
Our extensive review of the literature yielded only two 
articles describing constipation as a symptom of CD in 
children(5,6). These rare descriptions of constipation as an 
atypical manifestation of CD led Hungerford(9), in 1996, 
to write a letter to the editor of Australian Family Physician 
in which he revealed his disappointment with the paucity 
of reports of this symptom in pediatric patients, as, in his 
personal experience, chronic constipation was not unusual 
in adult patients with CD.
CD is increasingly recognized in adults with no present-
ing complaints of diarrhea. An ever greater percentage of 
patients are asymptomatic; diagnosis is often made during 
screening. Atypical forms of the disease are becoming more 
common(10). The North American Society for Pediatric 
Gastroenterology, Hepatology and Nutrition recommends 
that CD be considered in the differential diagnosis of chil-
dren with persistent gastrointestinal symptoms, including 
recurring abdominal pain, constipation, and vomiting(11). 
In 2007, a multicenter U.S. study showed that more wide-
spread CD screening could increase detection of the disease 
in the country(12). In this study, conducted between 2002 
and 2004, 22 cases of CD were diagnosed in a sample of 
976 subjects, four of whom reported constipation. This 
represented a very significant leap in the number of new 
cases from 0.27 per 1,000 to 11.6 per 1,000 screened.
Both patients described in this case report had chronic 
constipation and negative weight and height z scores. It 
is common knowledge that chronic constipation is highly 
prevalent among pediatric patients seeking specialized 
gastroenterology care, and that the vast majority of these 
cases are of functional etiology. However, when constipa-
tion presents alongside a variety of red flags, including 
compromised nutritional status, it should be regarded 
as an indication of in-depth diagnostic studies. In both 
patients described herein, constipation and signs of un-
dernutrition persisted during outpatient follow-up, which 
prompted assessment of digestive-absorptive function, 
leading to a diagnosis of CD.
To conclude, it bears stressing that CD may present 
in a variety of forms, namely: classical or symptomatic, 
asymptomatic, and atypical. Although there have been 
few descriptions of chronic constipation as a symptom 
of CD, the prevalence of this atypical manifestation does 
not appear to be negligible. Therefore, it is essential that 
healthcare providers be aware of it as a possible atypical 
presenting symptom of CD and pursue relevant investiga-
tions when the disease is suspected.
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